Treatment of Fibromyalgia With Recovery Factors

Treatment of Fibromyalgia With a Unique Polypeptide Nutritional Support

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04381780

Enrollment

100

Registered

2020-05-11

Start date

2020-05-06

Completion date

2021-01-15

Last updated

2021-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Fatigue Syndrome, Fibromyalgia

Brief summary

Treatment of Fibromyalgia and CFS with Recovery Factors

Detailed description

Use of a unique oral porcine peptide nutritional supplement in those meeting ACR 2010(amended) diagnostic criteria for Fibromyalgia or CDC Criteria for CFS

Interventions

DIETARY_SUPPLEMENTRecovery Factors

A unique porcine serum based polypeptide nutritional support

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Intervention model description

Open pilot study

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Meet the ACR 2010 Amended Fibromyalgia Diagnostic Criteria or CFS CDC criteria; Score 5 or less on Energy VAS

Exclusion criteria

Under 18 Pregnant Other severe complicating conditions \-

Design outcomes

Primary

Measure	Time frame	Description
Composite VAS	6 weeks	Composite of VAS for Fatigue, sleep, cognition, pain and overall well being

Secondary

Measure	Time frame	Description
FIQ-R	1 month	Fibromyalgia Impact Questionnaire

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026